IDEAS home Printed from https://ideas.repec.org/f/pba885.html
   My authors  Follow this author

Eliana Barrenho

(We have lost contact with this author. Please ask them to update the entry or send us the correct address or status for this person. Thank you.)

Personal Details

First Name:Eliana
Middle Name:
Last Name:Barrenho
Suffix:
RePEc Short-ID:pba885
[This author has chosen not to make the email address public]
The above email address does not seem to be valid anymore. Please ask Eliana Barrenho to update the entry or send us the correct address or status for this person. Thank you.

Affiliation

(50%) Business School
Imperial College

London, United Kingdom
http://www.imperial.ac.uk/business-school
RePEc:edi:sbimpuk (more details at EDIRC)

(50%) Directorate for Employment, Labour and Social Affairs (ELS)
Organisation de Coopération et de Développement Économiques (OCDE)

Paris, France
http://www.oecd.org/els/
RePEc:edi:eloecfr (more details at EDIRC)

Research output

as
Jump to: Working papers Articles Chapters

Working papers

  1. Marjolijn Moens & Eliana Barrenho & Valérie Paris, 2024. "Exploring the feasibility of sharing information on medicine prices across countries," OECD Health Working Papers 171, OECD Publishing.
  2. Eliana Barrenho & Marjolijn Moens & Lisbeth Waagstein & Ruth Lopert, 2023. "Enhancing competition in on-patent markets," OECD Health Working Papers 156, OECD Publishing.
  3. Eliana Barrenho & Philip Haywood & Candan Kendir & Nicolaas S. Klazinga, 2022. "International comparisons of the quality and outcomes of integrated care: Findings of the OECD pilot on stroke and chronic heart failure," OECD Health Working Papers 142, OECD Publishing.
  4. Eliana Barrenho & Ruth Lopert, 2022. "Exploring the consequences of greater price transparency on the dynamics of pharmaceutical markets," OECD Health Working Papers 146, OECD Publishing.
  5. Eliana Barrenho & Réka Halmai & Marisa Miraldo & Iván Tzintzun & Setti Raïs Ali & Léa Toulemon & Jean-Claude Dupont & Lise Rochaix, 2022. "Inequities in cancer drug development in terms of unmet medical need," Institut des Politiques Publiques halshs-03672739, HAL.
  6. Propper, Carol & Barrenho, Eliana & Gautier, Eric & Miraldo, Marisa & Rose, Christiern, 2020. "Innovation Diffusion and Physician Networks: Keyhole Surgery for Cancer in the English NHS," CEPR Discussion Papers 15515, C.E.P.R. Discussion Papers.
  7. Barrenho, E.; & Miraldo, M.; & Propper, C; & Rose, C.;, 2019. "Peer and network effects in medical innovation: the case of laparoscopic surgery in the English NHS," Health, Econometrics and Data Group (HEDG) Working Papers 19/10, HEDG, c/o Department of Economics, University of York.
  8. Barrenho, E & Smith, PC & Miraldo, M, 2013. "The determinants of attrition in drug development: a duration analysis," Working Papers 12204, Imperial College, London, Imperial College Business School.

Articles

  1. Eliana Barrenho & Eric Gautier & Marisa Miraldo & Carol Propper & Christiern Rose, 2025. "Innovation Diffusion Among Coworkers: Evidence from Senior Doctors," Management Science, INFORMS, vol. 71(10), pages 8109-8126, October.
  2. Anabela Coelho & Candan Kendir & Eliana Barrenho & Niek Klazinga & Cláudia Paiva & Joaquim Abreu de Sousa & Salomé Gonçalves-Monteiro & Patrícia Redondo & Ana Bastos & Armanda Nogueira & Fábio Botelho, 2023. "Patient-Reported Outcomes and Experiences Assessment in Women with Breast Cancer: Portuguese Case Study," IJERPH, MDPI, vol. 20(4), pages 1-11, February.
  3. Barrenho, Eliana & Halmai, Réka & Miraldo, Marisa & Tzintzun, Iván & Raïs Ali, Setti & Toulemon, Léa & Dupont, Jean-Claude K. & Rochaix, Lise, 2022. "Inequities in cancer drug development in terms of unmet medical need," Social Science & Medicine, Elsevier, vol. 302(C).
  4. Barrenho, Eliana & Miraldo, Marisa & Propper, Carol & Walsh, Brendan, 2021. "The importance of surgeons and their peers in adoption and diffusion of innovation: An observational study of laparoscopic colectomy adoption and diffusion in England," Social Science & Medicine, Elsevier, vol. 272(C).
  5. Eliana Barrenho & Marisa Miraldo & Peter C. Smith, 2019. "Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries," Health Economics, John Wiley & Sons, Ltd., vol. 28(1), pages 123-143, January.

Chapters

  1. Eliana Barrenho & Marisa Miraldo, 2018. "R&D Success in Pharmaceutical Markets: A Duration Model Approach," Contributions to Economic Analysis, in: Health Econometrics, volume 127, pages 201-233, Emerald Group Publishing Limited.

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Eliana Barrenho & Ruth Lopert, 2022. "Exploring the consequences of greater price transparency on the dynamics of pharmaceutical markets," OECD Health Working Papers 146, OECD Publishing.

    Cited by:

    1. Evert A. Manders & Sibren den Berg & Saco J. Visser & Carla E. M. Hollak, 2025. "Drug pricing models, no ‘one-size-fits-all’ approach: a systematic review and critical evaluation of pricing models in an evolving pharmaceutical landscape," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 26(4), pages 683-696, June.

  2. Eliana Barrenho & Réka Halmai & Marisa Miraldo & Iván Tzintzun & Setti Raïs Ali & Léa Toulemon & Jean-Claude Dupont & Lise Rochaix, 2022. "Inequities in cancer drug development in terms of unmet medical need," Institut des Politiques Publiques halshs-03672739, HAL.

    Cited by:

    1. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).

  3. Propper, Carol & Barrenho, Eliana & Gautier, Eric & Miraldo, Marisa & Rose, Christiern, 2020. "Innovation Diffusion and Physician Networks: Keyhole Surgery for Cancer in the English NHS," CEPR Discussion Papers 15515, C.E.P.R. Discussion Papers.

    Cited by:

    1. Marisa Miraldo & Carol Propper & Christiern Rose, 2020. "Identification of Peer Effects using Panel Data," Discussion Papers Series 639, School of Economics, University of Queensland, Australia.
    2. Meilin Möllenkamp & Benedetta Pongiglione & Stefan Rabbe & Aleksandra Torbica & Jonas Schreyögg, 2022. "Spillover effects and other determinants of medical device uptake in the presence of a medical guideline: An analysis of drug‐eluting stents in Germany and Italy," Health Economics, John Wiley & Sons, Ltd., vol. 31(S1), pages 157-178, September.
    3. Avdic, Daniel & von Hinke, Stephanie & Lagerqvist, Bo & Propper, Carol & Vikström, Johan, 2024. "Do responses to news matter? Evidence from interventional cardiology," Journal of Health Economics, Elsevier, vol. 94(C).
    4. McKibbin, Rebecca, 2023. "The effect of RCTs on drug demand: Evidence from off-label cancer drugs," Journal of Health Economics, Elsevier, vol. 90(C).

  4. Barrenho, E.; & Miraldo, M.; & Propper, C; & Rose, C.;, 2019. "Peer and network effects in medical innovation: the case of laparoscopic surgery in the English NHS," Health, Econometrics and Data Group (HEDG) Working Papers 19/10, HEDG, c/o Department of Economics, University of York.

    Cited by:

    1. Aureo de Paula & Imran Rasul & Pedro Souza, 2019. "Identifying Network Ties from Panel Data: Theory and an Application to Tax Competition," Papers 1910.07452, arXiv.org, revised Oct 2023.
    2. Raf Van Gestel & Niels Broekman & Tobias Müller, 2023. "Surgeon supply and healthcare quality: Are revision rates for hip and knee replacements lower in hospitals that employ more surgeons?," Health Economics, John Wiley & Sons, Ltd., vol. 32(10), pages 2298-2321, October.

  5. Barrenho, E & Smith, PC & Miraldo, M, 2013. "The determinants of attrition in drug development: a duration analysis," Working Papers 12204, Imperial College, London, Imperial College Business School.

    Cited by:

    1. Linde Colen & René Belderbos & Stijn Kelchtermans & Bart Leten, 2024. "Many are called, few are chosen: the role of science in drug development decisions," The Journal of Technology Transfer, Springer, vol. 49(2), pages 492-517, April.
    2. Michael Schlander & Karla Hernandez-Villafuerte & Chih-Yuan Cheng & Jorge Mestre-Ferrandiz & Michael Baumann, 2021. "How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment," PharmacoEconomics, Springer, vol. 39(11), pages 1243-1269, November.

Articles

  1. Barrenho, Eliana & Halmai, Réka & Miraldo, Marisa & Tzintzun, Iván & Raïs Ali, Setti & Toulemon, Léa & Dupont, Jean-Claude K. & Rochaix, Lise, 2022. "Inequities in cancer drug development in terms of unmet medical need," Social Science & Medicine, Elsevier, vol. 302(C).
    See citations under working paper version above.
  2. Barrenho, Eliana & Miraldo, Marisa & Propper, Carol & Walsh, Brendan, 2021. "The importance of surgeons and their peers in adoption and diffusion of innovation: An observational study of laparoscopic colectomy adoption and diffusion in England," Social Science & Medicine, Elsevier, vol. 272(C).

    Cited by:

    1. Godager , Geir & Scott, Anthony, 2023. "Physician Behavior and Health Outcomes," HERO Online Working Paper Series 2023:3, University of Oslo, Health Economics Research Programme.
    2. Meilin Möllenkamp & Benedetta Pongiglione & Stefan Rabbe & Aleksandra Torbica & Jonas Schreyögg, 2022. "Spillover effects and other determinants of medical device uptake in the presence of a medical guideline: An analysis of drug‐eluting stents in Germany and Italy," Health Economics, John Wiley & Sons, Ltd., vol. 31(S1), pages 157-178, September.
    3. Maynou, L. & McGuire, A. & Serra-Sastre, V., 2024. "What happens when the tasks dry up? Exploring the impact of medical technology on workforce planning," Social Science & Medicine, Elsevier, vol. 352(C).
    4. Méndez, Susan J. & Scott, Anthony & Zhang, Yuting, 2021. "Gender differences in physician decisions to adopt new prescription drugs," Social Science & Medicine, Elsevier, vol. 277(C).
    5. Maynou, Laia & McGuire, Alistair & Serra-Sastre, Victoria, 2024. "What happens when the tasks dry up? Exploring the impact of medical technology on workforce planning," LSE Research Online Documents on Economics 124065, London School of Economics and Political Science, LSE Library.
    6. Brick, Aoife & Walsh, Brendan & Kakoulidou, Theano & Humes, Harry, 2025. "Variation in day surgery rates across Irish public hospitals," Health Policy, Elsevier, vol. 152(C).
    7. Croft, Charlotte & Reay, Trish, 2025. "Breaching the professional social contract to drive system innovation: Nurse managers and the emergence of a new professional group," Social Science & Medicine, Elsevier, vol. 373(C).

  3. Eliana Barrenho & Marisa Miraldo & Peter C. Smith, 2019. "Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries," Health Economics, John Wiley & Sons, Ltd., vol. 28(1), pages 123-143, January.

    Cited by:

    1. Carolina Bueno & Rafael Macharete & Clarice Araújo Rodrigues & Felipe Kamia & Juliana Moreira & Camila Rizzini Freitas & Marco Nascimento & Carlos Grabois Gadelha, 2025. "Global Knowledge Asymmetries in Health: A Data-Driven Analysis of the Sustainable Development Goals (SDGs)," Sustainability, MDPI, vol. 17(14), pages 1-21, July.
    2. Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021. "R&D and market size: Who benefits from orphan drug legislation?," Journal of Health Economics, Elsevier, vol. 80(C).
    3. Eliana Barrenho & Réka Halmai & Marisa Miraldo & Iván Tzintzun & Setti Raïs Ali & Léa Toulemon & Jean-Claude Dupont & Lise Rochaix, 2022. "Inequities in cancer drug development in terms of unmet medical need," Institut des Politiques Publiques halshs-03672739, HAL.
    4. Javad Moradpour & Aidan Hollis, 2020. "Patient income and health innovation," Health Economics, John Wiley & Sons, Ltd., vol. 29(12), pages 1795-1803, December.
    5. Massimo FLORIO, 2020. "Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly," CIRIEC Working Papers 2008, CIRIEC - Université de Liège.
    6. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).
    7. Vijay Mohan & Munirul Nabin, 2023. "A note on disease burden and pharmaceutical R&D," Australian Economic Papers, Wiley Blackwell, vol. 62(4), pages 633-649, December.
    8. Rabbani, Maysam, 2021. "Mergers with Future Rivals Can Boost Prices, Intensify Market Concentration, and Bar Entry," MPRA Paper 112864, University Library of Munich, Germany, revised 26 Apr 2022.
    9. Simona Gamba & Laura Magazzini & Paolo Pertile, 2019. "R&D and market size: who benefits from orphan drug regulation?," Working Papers 09/2019, University of Verona, Department of Economics.

Chapters

  1. Eliana Barrenho & Marisa Miraldo, 2018. "R&D Success in Pharmaceutical Markets: A Duration Model Approach," Contributions to Economic Analysis, in: Health Econometrics, volume 127, pages 201-233, Emerald Group Publishing Limited.

    Cited by:

    1. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 8 papers announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.
  1. NEP-COM: Industrial Competition (5) 2021-04-12 2021-05-17 2022-09-19 2023-06-26 2024-09-30. Author is listed
  2. NEP-HEA: Health Economics (5) 2013-11-16 2019-08-12 2021-04-12 2021-05-17 2022-06-13. Author is listed
  3. NEP-EUR: Microeconomic European Issues (3) 2019-08-12 2021-04-12 2021-05-17
  4. NEP-URE: Urban and Real Estate Economics (3) 2019-08-12 2021-04-12 2021-05-17
  5. NEP-INO: Innovation (2) 2019-08-12 2021-04-12
  6. NEP-NET: Network Economics (2) 2021-04-12 2021-05-17
  7. NEP-REG: Regulation (2) 2022-09-19 2024-09-30
  8. NEP-IPR: Intellectual Property Rights (1) 2023-06-26
  9. NEP-SOC: Social Norms and Social Capital (1) 2019-08-12

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Eliana Barrenho should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.